Eliyahu Kraus

Title: **Eliyahu Kraus: Innovator in CPD Glycosylases**

Introduction

Eliyahu Kraus is a prominent inventor based in Sutton, Massachusetts, known for his significant contributions to the field of biotechnology. He holds a patent that showcases his innovative approach to enhancing the production of CPD glycosylases, which are crucial in addressing photosensitive diseases.

Latest Patents

Kraus's sole patent is titled "Production of CPD glycosylases." This groundbreaking invention details recombinant forms of DNA sequences for CPD glycosylases, including the bacteriophage T4 gene denV. The invention describes methods for expressing these glycosylases at high levels, allowing for the recovery of active CPD glycosylases from inclusion bodies through techniques involving homogenization and stream mixing. These active proteins have promising applications in topical formulations for treating photosensitive diseases. Furthermore, the stream mixing technique he patented can also aid in solubilizing other proteins beyond CPD glycosylases.

Career Highlights

Eliyahu Kraus has made a significant impact in the biotech sector through his role at Applied Genetics Incorporated Dermatics. His work has focused on advancing the understanding and applications of CPD glycosylases, contributing to innovative solutions in dermatological treatments.

Collaborations

Kraus collaborates with notable professionals in the field, including Daniel B Yarosh and Leonard F Estis. These collaborations reflect a synergy of expertise that drives innovation in their shared endeavors within biotechnological research and development.

Conclusion

Eliyahu Kraus stands out as an inventor whose work in the production of CPD glycosylases has the potential to revolutionize treatments for photosensitive diseases. His contributions through his patented technology and collaborations highlight the importance of innovation in biotechnology, showcasing how one inventor's efforts can lead to substantial advancements in medical applications.